PYCARD and non-small cell lung carcinoma: Virmani et al. reported that PYCARD methylation was seen in 41% (13 of 32) of small cell lung cancer tissues, 40% (28 of 70) of non-small-cell lung cancer tissues, and 32% (20 of 63) of breast cancer tissues [32].